LSTM Home > LSTM Research > LSTM Online Archive

How do health care providers deal with kala-azar in the Indian subcontinent?

Kumar, Narendra, Singh, Shri Prakash, Mondal, Dinesh, Joshi, Anand, Das, Pradeep, Sundar, Shyam, Kroeger, Axel, Hirve, Siddhivinayak, Siddiquil, N A and Boelaert, Marleen (2011) 'How do health care providers deal with kala-azar in the Indian subcontinent?'. Indian Journal of Medical Research, Vol 134, Issue 3, pp. 349-355.

[img]
Preview
Text
IndianJMedRes1343349-2522314_070023.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (452kB)

Abstract

Background & objectives : Three countries, Bangladesh, India and Nepal, set out to eliminate kala-azar by 2015. This study was aimed to document the knowledge and practices in kala-azar case management of public and private health providers in these three countries.
Methods: A health care provider survey was conducted in 2007 at 4 study sites, viz., Muzaffarpur and Vaishali districts in India, Mahottari district in Nepal, and Rajshahi district in Bangladesh. Interviews were conducted with formal and informal health care providers at their home or practice.
Results: About half of the providers in India and Nepal knew the rapid diagnostic test rK39 recommended by the elimination initiative, but this was not in Bangladesh. Knowledge of the recommended first-line drug, miltefosine, was good in India and Nepal but less so in Bangladesh.
Interpretation & conclusions : Innovative tools for VL care have not yet been fully taken up by private for profit care providers in the three countries that launched a VL elimination initiative. The elimination initiative needs to address these gaps in private providers' knowledge, given their substantial share in the care of VL patients.

Item Type: Article
Subjects: WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries
WA Public Health > Health Administration and Organization > WA 525 General works
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 715 Visceral leishmaniasis
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 765 Prevention and control
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 770 Therapy
Depositing User: Rachel Dominguez
Date Deposited: 19 Mar 2013 11:36
Last Modified: 27 Nov 2024 14:18
URI: https://archive.lstmed.ac.uk/id/eprint/3290

Statistics

View details

Actions (login required)

Edit Item Edit Item